L49-31652-36454
3 vaccinations
1 coded response
17 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 100 / NY
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-21
- 2021-05-12
- 2021-06-30
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-25
-
2022-01-01
Survey response — 3 months, dose 3MedDRA: Diarrhoea, Fatigue, Migraine, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Congestion, migraine, fatigue, sore throat, diahreeaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 3 months, dose 3
Symptoms: Congestion, migraine, fatigue, sore throat, diahreea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release